Compare AbbVie Inc (ABBV) vs Uranium Energy Corp (UEC) Price & Performance

AbbVie IncTrade

Uranium Energy CorpTrade

Price performance (Past 24H)

Key statistics

AbbVie Inc vs Uranium Energy Corp — how do they compare? AbbVie Inc trades at $248.12 (market cap $441.94B), while Uranium Energy Corp trades at $11.65 (market cap $5.67B). The key difference: AbbVie Inc is far larger — about 77.9× Uranium Energy Corp's market cap, and AbbVie Inc pays a 2.77% dividend while Uranium Energy Corp pays none. Which is the better fit depends on your goals.

	ABBV	UEC
Market Cap	$441.94B	$5.67B
Sector	Health	Energy
52-Week High	$263.58	$20.14
52-Week Low	$197.38	$9.04
Enterprise Value	$506.19B	$5.18B
Dividend Yield	2.77%	—

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

AbbVie Inc

AbbVie (ABBV) trades at $247.91, up 0.76% today, with a bullish technical signal and strong analyst support. Recent earnings beats and a 70.73% buy consensus highlight robust fundamentals, driven by Skyrizi and Rinvoq growth offsetting Humira declines. Positive news includes Phase 2 ovarian cancer data and institutional stake increases, reinforcing momentum.

Outlook remains positive with a $278.69 price target, though risks include patent cliffs and debt levels. Revenue growth and dividend stability offer appeal, but investors should monitor competitive pressures and regulatory developments for sustained performance.

Uranium Energy Corp

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ABBV

Fidelity Dividend ETF's payout is safe but not ideal for steady income due to variable quarterly dividends.24/7 Wall Street · 1 day agoNeutral Two Dividend Aristocrats outperformed the market while two lagged; three new picks show promising dividend growth.24/7 Wall Street · 2 days agoNeutral Healthcare sector leads S&P 500 gains over 3 months with key pharma stocks showing strong innovation and income potential.24/7 Wall Street · 2 days agoBullish View details →

UEC

NuScale Power shares fall 32% YTD amid revenue drop and dilution, awaiting key contracts to rebound.24/7 Wall Street · 22 hours agoBearish View details →

About AbbVie Inc

AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.

About Uranium Energy Corp

Uranium Energy Corp is a leading American uranium mining and exploration company, currently holding the largest resource base and licensed production capacity in the United States. Utilizing low-cost, environmentally friendly In-Situ Recovery (ISR) mining, UEC is a central player in the domestic nuclear fuel supply chain, transitioning from a resource holder to an active producer and refiner to meet the accelerating demand for carbon-free energy.